Posted by
The EndBrainCancer Initiative Partners with the National Cancer Institute (NCI) for Advocacy, Education and Placement into Clinical Trials for Brain Cancer Patients

The EndBrainCancer Initiative Partners with the National Cancer Institute (NCI) for Advocacy, Education and Placement into Clinical Trials for Brain Cancer Patients

The EndBrainCancer Initiative Partners with the National Cancer Institute (NCI) for Advocacy, Education and Placement into Clinical Trials for Brain Cancer Patients EndBrainCancer Initiative (EBCI) announces its new partnership with NCI-CONNECT to facilitate engagement with patients with rare CNS tumors (including various forms of brain cancer) and to advance research. 2018 NRG Announcement Press Release […]

Posted by

Dellann Elliott Mydland, President of the EndBrainCancer Initiative, to Serve on Two National Clinical Trial Committees for NRG Oncology, an NCI-Funded Research Group

Dellann Elliott Mydland, President of the EndBrainCancer Initiative, to Serve on Two National Clinical Trial Committees for NRG Oncology, an NCI-Funded Research Group As a member of the NRG brain tumor disease site committee, Mydland will advocate for patient perspectives and interests in assessing and recommending specific brain cancer clinical trials for funding to the […]

Posted by

The EndBrainCancer Initiative Received CITI Certification Becoming the First Brain Tumor Patient Advocacy Organization Listed as a Nationally-Recognized Recruiting Site

The EndBrainCancer Initiative Receives CITI Certification Becoming the First Brain Tumor Patient Advocacy Organization Listed as a Nationally-Recognized Recruiting Site FOR IMMEDIATE RELEASE Media Contact: Dellann Elliott Mydland Prestigious certification strengthens Seattle-based EBCI’s role in the brain tumor advocacy space directly connecting patients to Centers of Excellence, cutting edge treatments & development of promising clinical […]